Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 7/2014

01-07-2014 | Article

Doc2b enrichment enhances glucose homeostasis in mice via potentiation of insulin secretion and peripheral insulin sensitivity

Authors: Latha Ramalingam, Eunjin Oh, Debbie C. Thurmond

Published in: Diabetologia | Issue 7/2014

Login to get access

Abstract

Aims/hypothesis

Insulin secretion from pancreatic beta cells and insulin-stimulated glucose uptake into skeletal muscle are processes regulated by similar isoforms of the soluble N-ethylmaleimide-sensitive factor-attachment protein receptor (SNARE) and mammalian homologue of unc-18 (Munc18) protein families. Double C2 domain β (Doc2b), a SNARE- and Munc18-interacting protein, is implicated as a crucial effector of glycaemic control. However, whether Doc2b is naturally limiting for these processes, and whether Doc2b enrichment might exert a beneficial effect upon glycaemia in vivo, remains undetermined.

Methods

Tetracycline-repressible transgenic (Tg) mice engineered to overexpress Doc2b simultaneously in the pancreas, skeletal muscle and adipose tissues were compared with wild-type (Wt) littermate mice regarding glucose and insulin tolerance, islet function in vivo and ex vivo, and skeletal muscle GLUT4 accumulation in transverse tubule/sarcolemmal surface membranes. SNARE complex formation was further assessed using Doc2b overexpressing L6-GLUT4-myc myoblasts to derive mechanisms relatable to physiological in vivo analyses.

Results

Doc2b Tg mice cleared glucose substantially faster than Wt mice, correlated with enhancements in both phases of insulin secretion and peripheral insulin sensitivity. Heightened peripheral insulin sensitivity correlated with elevated insulin-stimulated GLUT4 vesicle accumulation in cell surface membranes of Doc2b Tg mouse skeletal muscle. Mechanistic studies demonstrated Doc2b enrichment to enhance syntaxin-4–SNARE complex formation in skeletal muscle cells.

Conclusions/interpretation

Doc2b is a limiting factor in SNARE exocytosis events pertinent to glycaemic regulation in vivo. Doc2b enrichment may provide a novel means to simultaneously boost islet and skeletal muscle function in vivo in the treatment and/or prevention of diabetes.
Appendix
Available only for authorised users
Literature
1.
Ohara-Imaizumi M, Fujiwara T, Nakamichi Y et al (2007) Imaging analysis reveals mechanistic differences between first- and second-phase insulin exocytosis. J Cell Biol 177:695–705PubMedCentralPubMedCrossRef
2.
Zhu D, Koo E, Kwan E et al (2013) Syntaxin-3 regulates newcomer insulin granule exocytosis and compound fusion in pancreatic beta cells. Diabetologia 56:359–369PubMedCrossRef
3.
Spurlin BA, Thurmond DC (2006) Syntaxin 4 facilitates biphasic glucose-stimulated insulin secretion from pancreatic beta-cells. Mol Endocrinol 20:183–193PubMedCrossRef
4.
Regazzi R, Wollheim CB, Lang J et al (1995) VAMP-2 and cellubrevin are expressed in pancreatic beta-cells and are essential for Ca(2+)-but not for GTP gamma S-induced insulin secretion. EMBO J 14:2723–2730PubMedCentralPubMed
5.
Sadoul K, Berger A, Niemann H et al (1997) SNAP-23 is not cleaved by botulinum neurotoxin E and can replace SNAP-25 in the process of insulin secretion. J Biol Chem 272:33023–33027PubMedCrossRef
6.
Zhu D, Zhang Y, Lam PP et al (2012) Dual role of VAMP8 in regulating insulin exocytosis and islet beta cell growth. Cell Metab 16:238–249PubMedCrossRef
7.
Klip A (2009) The many ways to regulate glucose transporter 4. Appl Physiol Nutr Metab 34:481–487PubMedCrossRef
8.
9.
Cheatham B, Volchuk A, Kahn CR, Wang L, Rhodes CJ, Klip A (1996) Insulin-stimulated translocation of GLUT4 glucose transporters requires SNARE-complex proteins. Proc Natl Acad Sci U S A 93:15169–15173PubMedCentralPubMedCrossRef
10.
Kawanishi M, Tamori Y, Okazawa H, Araki S, Shinoda H, Kasuga M (2000) Role of SNAP23 in insulin-induced translocation of GLUT4 in 3 T3-L1 adipocytes. Mediation of complex formation between syntaxin4 and VAMP2. J Biol Chem 275:8240–8247PubMedCrossRef
11.
Spurlin BA, Park SY, Nevins AK, Kim JK, Thurmond DC (2004) Syntaxin 4 transgenic mice exhibit enhanced insulin-mediated glucose uptake in skeletal muscle. Diabetes 53:2223–2231PubMedCrossRef
12.
Lam PP, Ohno M, Dolai S et al (2013) Munc18b is a major mediator of insulin exocytosis in rat pancreatic beta-cells. Diabetes 62:2416–2428PubMedCrossRef
13.
Oh E, Kalwat MA, Kim MJ, Verhage M, Thurmond DC (2012) Munc18-1 regulates first-phase insulin release by promoting granule docking to multiple syntaxin isoforms. J Biol Chem 287:25821–25833PubMedCentralPubMedCrossRef
14.
15.
Khan AH, Thurmond DC, Yang C, Ceresa BP, Sigmund CD, Pessin JE (2001) Munc18c regulates insulin-stimulated glut4 translocation to the transverse tubules in skeletal muscle. J Biol Chem 276:4063–4069PubMedCrossRef
16.
Tamori Y, Kawanishi M, Niki T et al (1998) Inhibition of insulin-induced GLUT4 translocation by Munc18c through interaction with syntaxin4 in 3 T3-L1 adipocytes. J Biol Chem 273:19740–19746PubMedCrossRef
17.
Thurmond DC, Ceresa BP, Okada S, Elmendorf JS, Coker K, Pessin JE (1998) Regulation of insulin-stimulated GLUT4 translocation by munc18c in 3T3L1 adipocytes. J Biol Chem 273:33876–33883PubMedCrossRef
18.
Tellam JT, Macaulay SL, McIntosh S, Hewish DR, Ward CW, James DE (1997) Characterization of Munc-18c and syntaxin-4 in 3 T3-L1 adipocytes. Putative role in insulin-dependent movement of GLUT-4. J Biol Chem 272:6179–6186PubMedCrossRef
19.
20.
Umahara M, Okada S, Yamada E et al (2008) Tyrosine phosphorylation of Munc18c regulates platelet-derived growth factor-stimulated glucose transporter 4 translocation in 3T3L1 adipocytes. Endocrinology 149:40–49PubMedCrossRef
21.
Jewell JL, Oh E, Ramalingam L et al (2011) Munc18c phosphorylation by the insulin receptor links cell signaling directly to SNARE exocytosis. J Cell Biol 193:185–199PubMedCentralPubMedCrossRef
22.
Bakke J, Bettaieb A, Nagata N, Matsuo K, Haj FG (2013) Regulation of the SNARE-interacting protein Munc18c tyrosine phosphorylation in adipocytes by protein-tyrosine phosphatase 1B. Cell Commun Signal 11:57PubMedCentralPubMedCrossRef
23.
Jewell JL, Oh E, Bennett SM, Meroueh SO, Thurmond DC (2008) The tyrosine phosphorylation of Munc18c induces a switch in binding specificity from syntaxin 4 to Doc2beta. J Biol Chem 283:21734–21746PubMedCentralPubMedCrossRef
24.
Ramalingam L, Oh E, Yoder SM et al (2012) Doc2b is a key effector of insulin secretion and skeletal muscle insulin sensitivity. Diabetes 61:2424–2432PubMedCentralPubMedCrossRef
25.
Ke B, Oh E, Thurmond DC (2007) Doc2beta is a novel Munc18c-interacting partner and positive effector of syntaxin 4-mediated exocytosis. J Biol Chem 282:21786–21797PubMedCrossRef
26.
Fukuda N, Emoto M, Nakamori Y et al (2009) DOC2B: a novel syntaxin-4 binding protein mediating insulin-regulated GLUT4 vesicle fusion in adipocytes. Diabetes 58:377–384PubMedCentralPubMedCrossRef
27.
Miyazaki M, Emoto M, Fukuda N et al (2009) DOC2b is a SNARE regulator of glucose-stimulated delayed insulin secretion. Biochem Biophys Res Commun 384:461–465PubMedCrossRef
28.
Yu H, Rathore SS, Davis EM, Ouyang Y, Shen J (2013) Doc2b promotes GLUT4 exocytosis by activating the SNARE-mediated fusion reaction in a calcium- and membrane bending-dependent manner. Mol Biol Cell 24:1176–1184PubMedCentralPubMedCrossRef
29.
Keller MP, Choi Y, Wang P et al (2008) A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility. Genome Res 18:706–716PubMedCentralPubMedCrossRef
30.
Schultze N, Burki Y, Lang Y, Certa U, Bluethmann H (1996) Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nat Biotechnol 14:499–503PubMedCrossRef
31.
Spurlin BA, Thomas RM, Nevins AK et al (2003) Insulin resistance in tetracycline-repressible Munc18c transgenic mice. Diabetes 52:1910–1917PubMedCrossRef
32.
Wiseman DA, Kalwat MA, Thurmond DC (2011) Stimulus-induced S-nitrosylation of syntaxin 4 impacts insulin granule exocytosis. J Biol Chem 286:16344–16354PubMedCentralPubMedCrossRef
33.
Stull ND, Breite A, McCarthy R, Tersey SA, Mirmira RG (2012) Mouse islet of Langerhans isolation using a combination of purified collagenase and neutral protease. J Vis Exp 67:e4137
34.
Zhou M, Sevilla L, Vallega G et al (1998) Insulin-dependent protein trafficking in skeletal muscle cells. Am J Physiol 275:E187–E196PubMed
35.
Walker PS, Ramlal T, Sarabia V et al (1990) Glucose transport activity in L6 muscle cells is regulated by the coordinate control of subcellular glucose transporter distribution, biosynthesis, and mRNA transcription. J Biol Chem 265:1516–1523PubMed
36.
Ferrannini E, Simonson DC, Katz LD et al (1988) The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metab Clin Exp 37:79–85PubMedCrossRef
37.
Edgerton DS, Lautz M, Scott M et al (2006) Insulin’s direct effects on the liver dominate the control of hepatic glucose production. J Clin Invest 116:521–527PubMedCentralPubMedCrossRef
38.
Schmelzle K, Kane S, Gridley S, Lienhard GE, White FM (2006) Temporal dynamics of tyrosine phosphorylation in insulin signaling. Diabetes 55:2171–2179PubMedCrossRef
39.
Groffen AJ, Friedrich R, Brian EC, Ashery U, Verhage M (2006) DOC2A and DOC2B are sensors for neuronal activity with unique calcium-dependent and kinetic properties. J Neurochem 97:818–833PubMedCrossRef
40.
Verhage M, de Vries KJ, Roshol H, Burbach JP, Gispen WH, Sudhof TC (1997) DOC2 proteins in rat brain: complementary distribution and proposed function as vesicular adapter proteins in early stages of secretion. Neuron 18:453–461PubMedCrossRef
41.
Mandic SA, Skelin M, Johansson JU, Rupnik MS, Berggren PO, Bark C (2011) Munc18-1 and Munc18-2 proteins modulate beta-cell Ca2+ sensitivity and kinetics of insulin exocytosis differently. J Biol Chem 286:28026–28040PubMedCentralPubMedCrossRef
Metadata
Title
Doc2b enrichment enhances glucose homeostasis in mice via potentiation of insulin secretion and peripheral insulin sensitivity
Authors
Latha Ramalingam
Eunjin Oh
Debbie C. Thurmond
Publication date
01-07-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 7/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3227-7

Other articles of this Issue 7/2014

Diabetologia 7/2014 Go to the issue

Article

Hepatic 11β-hydroxysteroid dehydrogenase type 1 activity in obesity and type 2 diabetes using a novel triple tracer cortisol technique

Article

Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes

Article

Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial

Article

Methylglyoxal impairs endothelial insulin sensitivity both in vitro and in vivo

Article

Validation of a model to estimate personalised screening frequency to monitor diabetic retinopathy

Commentary

The efficacy and effectiveness of drugs for diabetes: how do clinical trials and the real world compare?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits